Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TXG · against 177 other Healthcare companies of similar size
Ranked #102 of 178 · scores higher than 43% of peers · safety percentile 40
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)21 peers with a safety percentile of 40–49, including TXG · Click a bar to see the companies
A mix: stronger current ratio and debt / equity, but weaker beta than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | TXG | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 172 reported | 0.10× | 0.33× | 71% | 33% | |
| BetaLower is better · 179 reported | 2.08 | 0.58 | 6% | 33% | |
| Current ratioHigher is better · 169 reported | 5.69× | 2.48× | 79% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 10.1B EUR (≈$11.1B) | 99 | ||
| 4 | 9.0B USD | 98 | 51 | |
| 5 | 4.6B USD | 98 | 29 | |
| 98 | 71.0B HKD (≈$9.1B) | 42 | 54 | |
| 99 | 9.0B USD | 41 | 57 | |
| 100 | 34.9B CNY (≈$4.9B) | 41 | 16 | |
| 101 | 884.9B JPY (≈$6.0B) | 41 | 61 | |
| 102 | 8.5B USD | 40 | 28 | |
| 103 | 47.8B HKD (≈$6.1B) | 40 | 58 | |
| 104 | 4.3B USD | 40 | 54 | |
| 105 | 4.4B USD | 39 | 66 | |
| 106 | 7.4B USD | 37 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score